InfuSystem Holdings (INFU) Shares Outstanding (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Shares Outstanding (Entity) came in at $20.2 million in Q1 2026, down 3.79% YoY from $21.0 million in Q1 2025, and little changed on a QoQ basis from $20.2 million in Q4 2025.
InfuSystem Holdings (INFU) Shares Outstanding (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Shares Outstanding (Entity) data on file, last reported at $20.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 3.79% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (down 3.79% YoY) and the FY2025 annual result came in at $20.2 million, down 5.0% from the prior year.
- Shares Outstanding (Entity) was little changed at $20.2 million in Q1 2026, from $20.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $21.3 million in Q2 2024 to a low of $20.2 million in Q1 2026.
- A 5-year average of $20.8 million and a median of $20.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) decreased 14.32% — and 2023, when it grew 2.48%.
- Tracing INFU's Shares Outstanding (Entity) over 5 years: stood at $20.8 million in 2022, then rose by 2.0% to $21.2 million in 2023, then climbed by 0.36% to $21.3 million in 2024, then dropped by 5.0% to $20.2 million in 2025, then dropped by 0.15% to $20.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $20.2 million (Q1 2026), $20.2 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 97.60 Mn |
| 10 | InfuSystem Holdings | 245.67 Mn | 244.71 Mn | 21.41 Mn | 20.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.07 Mn |
| Mar 31, 2026 | 20.21 Mn |
| Dec 31, 2025 | 20.66 Mn |
| Sep 30, 2025 | 20.41 Mn |
| Jun 30, 2025 | 20.81 Mn |
| Mar 31, 2025 | 21.13 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Sep 30, 2024 | 21.29 Mn |
| Jun 30, 2024 | 21.30 Mn |
| Mar 31, 2024 | 21.23 Mn |
| Dec 31, 2023 | 21.02 Mn |
| Sep 30, 2023 | 21.10 Mn |
| Jun 30, 2023 | 20.96 Mn |
| Mar 31, 2023 | 20.85 Mn |
| Dec 31, 2022 | 20.65 Mn |
| Sep 30, 2022 | 20.68 Mn |
| Jun 30, 2022 | 20.58 Mn |
| Mar 31, 2022 | 20.61 Mn |
| Dec 31, 2021 | 20.52 Mn |
| Sep 30, 2021 | 20.58 Mn |